Polypharmacy as an ordered indicator of therapeutic complexity in a national cardiovascular prevention programme.

Front Pharmacol · 2026 · PMC13139143 · PMID 42093879

Europe PMC DOI

hedged sentence

0.2200

closest p · 4.4× alpha

0.2200

boldest claim

The sentences

did not reach statistical significancep = 0.22not close (p > 0.1)

Median age increased slightly from 47 years (IQR 44–50) in the ≤5-drug group to 49 years (IQR 46–51) in the ≥7-drug group, yet this shift did not reach statistical significance (HL = −1.0; 95% CI, −3.0 to 1.0; p = 0.22).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.